Novavax | NVAX - Ebitda





Ebitda Изменить Дата
Adma Biologics USD 73.59M 14.85M 2025-12
Agenus USD -10.11M 19.02M 2025-03
AstraZeneca USD 5.23B 272M 2025-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Cassava Sciences USD -11.73M 33.44M 2025-09
Geron USD -9.47M 1.92M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
MannKind USD 17.92M 8.17M 2025-09
Merck USD 8.39B 1.97B 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Moderna USD -790M 582M 2025-12
Novartis USD 5.84B 235M 2025-09
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.08B 351M 2025-09
Sanofi EUR 4.84B 2.95B 2025-09
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
TG Therapeutics USD 32.69M 5M 2025-09